Pigmentbio C-Concentrate: A highly effective night serum

Pigmentbio C-Concentrate is a vitamin C night serum that strengthens and protects the skin barrier. It contains a vitamin cocktail and a high concentration of AHA/BHA, which provides a gentle exfoliating effect.

Light and non-comedogenic texture

This serum comes in a compact 15ml bottle with a feather-light texture and is non-comedogenic. LumiReveal™ Technology helps reduce dark spots and prevents the formation of new ones.

Potent ingredients

With 2% fresh vitamin C, it helps reduce dark spots and prevent their formation. AHA and BHA smooth the skin, while niacinamide (vitamin B3) strengthens the skin barrier and provides hydration for 8 hours. Vitamins C and E offer protection against oxidative stress and brighten the complexion.

Lightening hyperpigmentation

People prone to hyperpigmentation, triggered by sun exposure, age, pregnancy, or scarring, benefit from this serum. BIODERMA LumiReveal™ Technology, inspired by dermatological methods, addresses the three phases of hyperpigmentation:

• Glabridin reduces inflammation.
• Andrographolide reduces melanin production.
• Promotes cell renewal with Epidermactiv.

Enriched with vitamins C, E and niacinamide, the serum strengthens the skin barrier and provides an exfoliating effect through glycolic and salicylic acid, without drying out the skin.

After one month, there can be a 45% reduction in dark spots, and 87% of users report increased radiance, 85% a more even complexion.

Instructions for use

The product should be used as monotherapy for 1 to 3 months. The cap must be firmly pressed down before use to release the vitamin C, and the bottle shaken to mix the serum. Apply 5 drops in the evening after cleansing. Sunscreen in the morning is recommended.

A slight tingling sensation may occur initially. If irritation persists, the product should be discontinued and a doctor consulted.

Further information

Developed in a French research laboratory in Aix-en-Provence, the product is dermatologically tested and recommended by dermatologists.

• [BI 758]
• Clinical study with melasma patients over 5 months, 55 volunteers - Brazil.
• Test conducted under dermatological supervision with 21 volunteers, aged 24 to 48 years, for 56 days.